Mag-Al

Dosage form: liquid
Ingredients: MAGNESIUM HYDROXIDE 1200mg in 30mL, ALUMINUM HYDROXIDE 1200mg in 30mL
Labeler: Cardinal Health
NDC Code: 55154-9431

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Mag-AL Liquid

A Sugar-Free Antacid

Maalox is a registered trademark of Novartis Consumer Health, Inc.

Compare to the active ingredients in Maalox®

DESCRIPTION

Each 5 mL (teaspoonful) contains 200 mg aluminum hydroxide (equiv. to dried gel, USP) and 200 mg magnesium hydroxide and provides approximately 9 mEq of acid-neutralizing capacity (ANC).

Inactive Ingredients

Antifoam, butylparaben, hydroxypropyl methylcellulose, flavoring, propylene glycol, propylparaben, purified water, sodium saccharin, and sorbitol solution.

Sodium content: 4 mg/5 mL

INDICATIONS

As an antacid for symptomatic relief of hyperacidity associated with the diagnosis of peptic ulcer, gastritis, peptic esophagitis, gastric hyperacidity, or hiatal hernia.

DIRECTIONS

Shake well before using. Adults and children 12 years and older: 10 mL to 20 mL (2 to 4 teaspoonfuls) four times a day or as directed by a physician. Children under 12 years: consult a physician.

WARNINGS

The maximum recommended daily dosage of this product is 80 mL (16 teaspoonfuls). Do not take more than this dosage in a 24-hour period or use this dosage for more than 2 weeks except under the advice and supervision of a physician. Do not use this product except under the advice and supervision of a physician if you have kidney disease. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health professional before using this product.

Prolonged use of aluminum-containing antacids in patients with renal failure may result in or worsen dialysis osteomalacia. Elevated tissue aluminum levels contribute to the development of the dialysis encephalopathy and osteomalacia syndromes. Small amounts of aluminum are absorbed from the gastrointestinal tract and renal excretion of aluminum is impaired in renal failure. Aluminum is not well removed by dialysis because it is bound to albumin and transferrin, which do not cross dialysis membranes. As a result, aluminum is deposited in bone, and dialysis osteomalacia may develop when large amounts of aluminum are ingested orally by patients with impaired renal function.

Aluminum forms insoluble complexes with phosphate in the gastrointestinal tract, thus decreasing phosphate absorption. Prolonged use of aluminum-containing antacids by normophosphatemic patients may result in hypophosphatemia if phosphate intake is not adequate. In its more severe forms, hypophosphatemia can lead to anorexia, malaise, muscle weakness, and osteomalacia.

KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.

DRUG INTERACTION PRECAUTION

Ask a doctor or pharmacist before use if you are presently taking a prescription drug. Antacids may interact with certain prescription drugs.

HOW SUPPLIED

White colored, peppermint flavored liquid supplied in the following oral dosage form: NDC 0121-1760-30 (unit dose cups of 30 mL, 10 × 10's).

STORAGE

Keep tightly closed. Store at controlled room temperature, 20° to 25°C (68° to 77°F) [See USP]. Protect from freezing.

R04/14

Pharmaceutical
Associated, Inc.
Greenville, SC 29605

Principal Display Panel

Mag-Al Liquid

5 Unit Dose Cups

MAG-AL 
magnesium hydroxide, aluminum hydroxide liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:55154-9431(NDC:0121-1760)
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MAGNESIUM HYDROXIDE (MAGNESIUM CATION) MAGNESIUM HYDROXIDE1200 mg  in 30 mL
ALUMINUM HYDROXIDE (ALUMINUM HYDROXIDE) ALUMINUM HYDROXIDE1200 mg  in 30 mL
Inactive Ingredients
Ingredient NameStrength
BUTYLPARABEN 
HYPROMELLOSES 
PROPYLENE GLYCOL 
PROPYLPARABEN 
WATER 
SACCHARIN SODIUM 
SORBITOL 
Product Characteristics
ColorWHITEScore    
ShapeSize
FlavorPEPPERMINTImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:55154-9431-55 CUP, UNIT-DOSE in 1 BAG
130 mL in 1 CUP, UNIT-DOSE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other06/07/2011
Labeler - Cardinal Health (188557102)
Establishment
NameAddressID/FEIOperations
Cardinal Health188557102REPACK(55154-9431)

Revised: 10/2014
 
Cardinal Health

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web4)